Literature DB >> 26885695

Phenotypic observations in "hypotrichosis with juvenile macular dystrophy" (recessive CDH3 mutations).

Arif O Khan1,2, Hanno J Bolz2,3,4.   

Abstract

PURPOSE: Recessive mutations in CDH3 cause "hypotrichosis with juvenile macular dystrophy," typically recognized by the presence of prominent dermatological features. We report novel phenotypic observations and associated mutations in four patients from three families, including one who did not have frank hypotrichosis.
METHODS: Retrospective case series (2010-2014).
RESULTS: Four affected individuals from three consanguineous Arabian families were identified. All four subjects (two sisters and two unrelated males; 5, 13, 17, and 26 years old) had homozygous recessive CDH3 mutations not previously associated with the condition (c.307C>T; p.R103 in two sisters, c.1859_1862delCTCT in both unrelated males). Symptomatic visual loss was since birth or early childhood. One male subject did not have frank hypotrichosis, but review of symptoms revealed relatively slow hair growth and an inability to conceive children. None had dental or digital findings, although one female noted slow nail growth. All had a circumscribed central maculopathy with borders that did not respect posterior pole horizontal arterioles (typically extending beyond the major arcades) and associated with polygonal pigment clumping. Recognition of this pattern led us to suspect the diagnosis in the male without frank hypotrichosis. Retinal dysfunction was cone-rod (rather than macular only) by ERG in one patient, who developed severe central macular atrophy and a macular hole.
CONCLUSIONS: Ophthalmologists should consider the diagnosis of CDH3-related retinopathy in individuals with such clinical features whether or not there is frank hypotrichosis.

Entities:  

Keywords:  CDH3; hypotrichosis; macular dystrophy; retinal dystrophy

Mesh:

Substances:

Year:  2016        PMID: 26885695     DOI: 10.3109/13816810.2015.1071411

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  6 in total

1.  Hypotrichosis with cone-rod dystrophy in a patient with cadherin 3 (CDH3) mutation.

Authors:  F Nasser; L Mulahasanovic; M Alkhateeb; S Biskup; K Stingl; E Zrenner
Journal:  Doc Ophthalmol       Date:  2019-02-01       Impact factor: 2.379

2.  Whole exome sequencing analysis identifies novel Stargardt disease-related gene mutations in Chinese Stargardt disease and retinitis pigmentosa patients.

Authors:  Tsz Kin Ng; Yingjie Cao; Xiang-Ling Yuan; Shaowan Chen; Yanxuan Xu; Shao-Lang Chen; Yuqian Zheng; Haoyu Chen
Journal:  Eye (Lond)       Date:  2021-04-12       Impact factor: 3.775

3.  CDH3 gene related hypotrichosis and juvenile macular dystrophy - A case with a novel mutation.

Authors:  Omer Karti; Saygin Abali; Ziya Ayhan; Eylem Gokmeydan; Serhad Nalcaci; Aylin Yaman; Ali Osman Saatci
Journal:  Am J Ophthalmol Case Rep       Date:  2017-06-26

4.  New CDH3 mutation in the first Spanish case of hypotrichosis with juvenile macular dystrophy, a case report.

Authors:  Fiona Blanco-Kelly; Luciana Rodrigues-Jacy da Silva; Iker Sanchez-Navarro; Rosa Riveiro-Alvarez; Miguel Angel Lopez-Martinez; Marta Corton; Carmen Ayuso
Journal:  BMC Med Genet       Date:  2017-01-07       Impact factor: 2.103

5.  Hypotrichosis with juvenile macular dystrophy: Combination of whole-genome sequencing and genome-wide homozygosity mapping identifies a large deletion in CDH3 initially undetected by whole-exome sequencing-A lesson from next-generation sequencing.

Authors:  Amir Hossein Saeidian; Hassan Vahidnezhad; Leila Youssefian; Soheila Sotudeh; Meisam Sargazi; Sirous Zeinali; Jouni Uitto
Journal:  Mol Genet Genomic Med       Date:  2019-09-27       Impact factor: 2.183

6.  Multimodal imaging of Hypotrichosis with juvenile macular dystrophy: a case report.

Authors:  Giovanna Carnovale Scalzo; Adriano Carnevali; Gabriele Piccoli; Domenico Ceravolo; Donatella Bruzzichessi; Rodolfo Iuliano; Rossana Tallerico; Valentina Gatti; Giuseppe Giannaccare; Vincenzo Scorcia
Journal:  BMC Ophthalmol       Date:  2021-07-23       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.